Results 161 to 170 of about 2,363,153 (402)
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer
Molecular Oncology, EarlyView.Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte +10 more
wiley +1 more source
Point of care testing of GBS, isn’t it obvious? [PDF]
, 2018 Review of group B streptococcal diseases in newborns, of prevention strategies. Review of advantages and weakness of antenatal screening. A rapid test is needed for intrapartum screening: why, expected advantages and weakness, Wishlist of expected ...
Melin, Pierrette
core
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Point-of-Care Testing/Point-of-Care Testing
LaboratoriumsMedizin, 2002 Angelika Heinschink, Mathias Müller
openaire +2 more sources
Point-of-Care Testing of Blood Lactate. Point-of-Care Testing of Blood Lactate
Laboratoriums Medizin, 2002 Summary: Point-of-care (POC) technology brings laboratory testing to the patient's bedside through the use of hand-held or bench-top analyzers. This in turn is beneficial to patient care by decreasing turn-around time, facilitating clinical decision making, and decreasing pre- and post-analytical errors.
openaire +3 more sources
Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa [PDF]
Objectives: Chlamydia is the most common bacterial sexually transmitted infection worldwide and a major cause of morbidity – particularly among women and neonates.
Hjortdahl, Per +6 more
core
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source